Product Information
CICLOPIROX 8% SOLUTION is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $1.1541 per ML under NDC 45802014167. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Sep 18, 2007. Its Orange Book therapeutic-equivalence code is AT.
Strength
80 mg/mL
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802014167
Classification
Generic
Dosage Form
SOLUTION
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
CICLOPIROXApproval Type
Generic (ANDA)
FDA Application
ANDA077623FDA Approved
9/18/2007
TE Code
AT
On Market Since
9/19/2007
Pharmacological Classes
Price Statistics
The NADAC for CICLOPIROX 8% SOLUTION has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 70.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1541 per ML |
|---|---|
| All-time high | $4.6265 (Jan 15, 2014) |
| All-time low | $1.1541 (Sep 23, 2026) |
| 52-week high | $1.4170 |
| 52-week low | $1.1541 |
| Median price | $2.0332 |
| Average price | $2.4442 |
| Largest weekly change | -27.3% (Nov 20, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Padagis Israel Pharmaceuticals Ltd manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ciclopirox market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CICLOPIROX 8% SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for CICLOPIROX 8% SOLUTION, manufactured by Padagis Israel Pharmaceuticals Ltd, is $1.1541 per ML (NDC 45802014167), effective Sep 30, 2026.
How has the price of CICLOPIROX 8% SOLUTION changed over time?
Over the history we have for it, the NADAC for CICLOPIROX 8% SOLUTION has declined 70.1%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CICLOPIROX 8% SOLUTION?
Since Nov 28, 2013, the NADAC for CICLOPIROX 8% SOLUTION has ranged from a low of $1.1541 (Sep 23, 2026) to a high of $4.6265 (Jan 15, 2014), with a median of $2.0332 per ML.
Are there cheaper alternatives to CICLOPIROX 8% SOLUTION?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CICLOPIROX 8% SOLUTION in a comparable dosage form, but none are currently priced below it.
Who manufactures CICLOPIROX 8% SOLUTION?
CICLOPIROX 8% SOLUTION (NDC 45802014167) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.